Drug-induced lymphocyte stimulation test in the prediction of drug-induced hypersensitivity to antituberculosis drugs

Abstract Antituberculosis (TB) chemotherapeutic drugs may cause a variety of adverse drug reactions (ADRs). To assess the potential of drug-induced lymphocyte stimulation test (DLST) in screening ADRs in patients treated with anti-TB drugs, we performed DLST in 272 TB patients (176 cases with ADRs a...

Full description

Saved in:
Bibliographic Details
Published inDiagnostic microbiology and infectious disease Vol. 82; no. 2; pp. 172 - 176
Main Authors Sun, Qin, Sha, Wei, Gui, Xu-Wei, Xiao, Yang-Jiong, Zeng, Wei-Hong, Sun, Wen-Wen, Xiao, He-Ping, Ye, Wei-Yi
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.06.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Antituberculosis (TB) chemotherapeutic drugs may cause a variety of adverse drug reactions (ADRs). To assess the potential of drug-induced lymphocyte stimulation test (DLST) in screening ADRs in patients treated with anti-TB drugs, we performed DLST in 272 TB patients (176 cases with ADRs and 96 controls without ADRs) treated with anti-TB drugs isoniazid (INH), rifampicin (RFP), ethambutol (EMB), and pyrazinamide (PZA). The ADRs were diagnosed by drug provocation test based on clinical and laboratory examinations. The sensitivities of DLST in the diagnosis of INH-, RFP-, EMB-, or PZA-induced ADRs were 57.8%, 37.1%, 42.4%, and 23.1%, respectively, with the corresponding specificities being 93.4%, 94.0%, 97.5%, and 98.8%. DLST has high specificity and limited sensitivity in the diagnosis of anti-TB drug-induced ADRs. In combination with clinical observation and drug use history, DLST could have a predictive validity of ADRs, especially when a positive result is obtained.
AbstractList Antituberculosis (TB) chemotherapeutic drugs may cause a variety of adverse drug reactions (ADRs). To assess the potential of drug-induced lymphocyte stimulation test (DLST) in screening ADRs in patients treated with anti-TB drugs, we performed DLST in 272 TB patients (176 cases with ADRs and 96 controls without ADRs) treated with anti-TB drugs isoniazid (INH), rifampicin (RFP), ethambutol (EMB), and pyrazinamide (PZA). The ADRs were diagnosed by drug provocation test based on clinical and laboratory examinations. The sensitivities of DLST in the diagnosis of INH-, RFP-, EMB-, or PZA-induced ADRs were 57.8%, 37.1%, 42.4%, and 23.1%, respectively, with the corresponding specificities being 93.4%, 94.0%, 97.5%, and 98.8%. DLST has high specificity and limited sensitivity in the diagnosis of anti-TB drug-induced ADRs. In combination with clinical observation and drug use history, DLST could have a predictive validity of ADRs, especially when a positive result is obtained.
Antituberculosis (TB) chemotherapeutic drugs may cause a variety of adverse drug reactions (ADRs). To assess the potential of drug-induced lymphocyte stimulation test (DLST) in screening ADRs in patients treated with anti-TB drugs, we performed DLST in 272 TB patients (176 cases with ADRs and 96 controls without ADRs) treated with anti-TB drugs isoniazid (INH), rifampicin (RFP), ethambutol (EMB), and pyrazinamide (PZA). The ADRs were diagnosed by drug provocation test based on clinical and laboratory examinations. The sensitivities of DLST in the diagnosis of INH-, RFP-, EMB-, or PZA-induced ADRs were 57.8%, 37.1%, 42.4%, and 23.1%, respectively, with the corresponding specificities being 93.4%, 94.0%, 97.5%, and 98.8%. DLST has high specificity and limited sensitivity in the diagnosis of anti-TB drug-induced ADRs. In combination with clinical observation and drug use history, DLST could have a predictive validity of ADRs, especially when a positive result is obtained. •Drug-induced lymphocyte stimulation test (DLST) and drug provocation test (DPT) were compared in detecting adverse drug reactions (ADRs) in TB patients.•Four anti-TB drugs were tested: isoniazid, rifampicin, ethambutol, and pyrazinamide.•DLST has high specificity and limited sensitivity in the diagnosis of anti-TB drug-induced ADRs.
Abstract Antituberculosis (TB) chemotherapeutic drugs may cause a variety of adverse drug reactions (ADRs). To assess the potential of drug-induced lymphocyte stimulation test (DLST) in screening ADRs in patients treated with anti-TB drugs, we performed DLST in 272 TB patients (176 cases with ADRs and 96 controls without ADRs) treated with anti-TB drugs isoniazid (INH), rifampicin (RFP), ethambutol (EMB), and pyrazinamide (PZA). The ADRs were diagnosed by drug provocation test based on clinical and laboratory examinations. The sensitivities of DLST in the diagnosis of INH-, RFP-, EMB-, or PZA-induced ADRs were 57.8%, 37.1%, 42.4%, and 23.1%, respectively, with the corresponding specificities being 93.4%, 94.0%, 97.5%, and 98.8%. DLST has high specificity and limited sensitivity in the diagnosis of anti-TB drug-induced ADRs. In combination with clinical observation and drug use history, DLST could have a predictive validity of ADRs, especially when a positive result is obtained.
Author Sha, Wei
Gui, Xu-Wei
Xiao, Yang-Jiong
Sun, Wen-Wen
Xiao, He-Ping
Ye, Wei-Yi
Sun, Qin
Zeng, Wei-Hong
Author_xml – sequence: 1
  fullname: Sun, Qin
– sequence: 2
  fullname: Sha, Wei
– sequence: 3
  fullname: Gui, Xu-Wei
– sequence: 4
  fullname: Xiao, Yang-Jiong
– sequence: 5
  fullname: Zeng, Wei-Hong
– sequence: 6
  fullname: Sun, Wen-Wen
– sequence: 7
  fullname: Xiao, He-Ping
– sequence: 8
  fullname: Ye, Wei-Yi
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25863530$$D View this record in MEDLINE/PubMed
BookMark eNqNks1u1TAQhS1URG8Lr4AiVmySjuM4cVggoZafSpVYAGvLcSa9c0niYDuV8vZNeguq2MBqpNE5M5rzzRk7Gd2IjL3hkHHg5cUha8ncDmS9a8hlOXCZgcgA1DO246qqU4AKTtgOKpGnStXilJ2FcADgeV3AC3aaS1UKKWDH5is_36Y0trPFNumXYdo7u0RMQqRh7k0kNyYRQ0xorXtMJo8t2Ye265L2qXu_TOgDjoEi3VFckugSM0aKc4Pezr0LFB4c4SV73pk-4KvHes5-fPr4_fJLevP18_Xlh5vUSqFiymvA0naiVrJuG1lYqKtOyDbvUBaGm6asOmOKBi3vBAohlehMKVthVIcWCnHO3h7nTt79mtcr9EDBYt-bEd0cNK-KUikuAf4tLRXUUnFRr9J3R-kKIASPnZ48DcYvmoPeCOmDfkpIb4Q0CL0SWs2vH_fMzYDtH-tvJKvg6ijANZg7Qq-DJRzXgMmjjbp19H973v81xvY0kjX9T1wwHNzsxzV6zXXINehv269sr7KFAVVRiXt4lcMy
CitedBy_id crossref_primary_10_1007_s12035_016_9936_9
crossref_primary_10_3389_fmed_2022_923991
crossref_primary_10_1111_cod_13296
crossref_primary_10_1111_ped_13937
crossref_primary_10_18821_0869_2084_2020_65_9_552_556
crossref_primary_10_1111_cea_13076
crossref_primary_10_33590_emjallergyimmunol_10312402
crossref_primary_10_7868_S2587667819030099
crossref_primary_10_4168_aair_2021_13_2_245
crossref_primary_10_1016_j_jaip_2017_11_021
crossref_primary_10_1097_MOP_0000000000000489
Cites_doi 10.1016/S1081-1206(10)62890-6
10.2169/internalmedicine.46.0086
10.1111/j.1365-2222.1997.tb00690.x
10.1001/jama.1997.03550220101014
10.1034/j.1398-9995.2003.00279.x
10.1111/j.1398-9995.2009.02143.x
10.1016/S0140-6736(10)62173-3
10.1007/s10156-010-0189-7
10.5588/ijtld.11.0163
10.1038/nm.1884
10.1016/j.jdermsci.2011.12.002
10.1111/j.1365-2230.2005.01913.x
10.1164/rccm.167.4.603
10.2310/7480.2007.00006
10.1378/chest.07-3088
10.1111/j.1365-2133.2008.08875.x
10.1186/1465-9921-13-39
10.1016/j.tube.2011.12.004
10.1016/j.jdermsci.2007.05.013
10.1111/j.1447-0756.2011.01756.x
10.1146/annurev.pharmtox.45.120403.100058
10.1080/10408440590935620
ContentType Journal Article
Copyright Elsevier Inc.
2015 Elsevier Inc.
Copyright © 2015 Elsevier Inc. All rights reserved.
Copyright_xml – notice: Elsevier Inc.
– notice: 2015 Elsevier Inc.
– notice: Copyright © 2015 Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
7T5
H94
DOI 10.1016/j.diagmicrobio.2015.03.008
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
Immunology Abstracts
AIDS and Cancer Research Abstracts
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
DatabaseTitleList AIDS and Cancer Research Abstracts
MEDLINE


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1879-0070
EndPage 176
ExternalDocumentID 10_1016_j_diagmicrobio_2015_03_008
25863530
S0732889315000747
1_s2_0_S0732889315000747
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29G
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AAAJQ
AABNK
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AAXKI
AAXUO
ABBQC
ABFNM
ABFRF
ABJNI
ABMAC
ABMZM
ABXDB
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AEVXI
AFCTW
AFFNX
AFJKZ
AFKWA
AFRHN
AFTJW
AFXIZ
AGEKW
AGHFR
AGUBO
AGYEJ
AHHHB
AI.
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CJTIS
CNWQP
CS3
DU5
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEJ
HMG
HMK
HMO
HVGLF
HZ~
IHE
J1W
KOM
LUGTX
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OD-
OO.
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SIN
SPCBC
SSH
SSI
SSZ
T5K
UNMZH
VH1
WUQ
XPP
Z5R
ZGI
ZXP
~G-
AAIAV
ABLVK
ABYKQ
AJBFU
EFLBG
LCYCR
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
7T5
H94
ID FETCH-LOGICAL-c538t-190e6cf39859db54c097f35d2fe54a1ab67faa4bec1f3e33583fa65d3a8fec043
IEDL.DBID AIKHN
ISSN 0732-8893
IngestDate Fri Aug 16 21:44:42 EDT 2024
Sat Oct 05 05:59:16 EDT 2024
Thu Sep 26 18:17:31 EDT 2024
Sat Sep 28 07:56:30 EDT 2024
Fri Feb 23 02:27:16 EST 2024
Tue Oct 15 22:53:20 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Tuberculosis
Adverse drug reaction
Drug-induced hypersensitivity
Drug-induced lymphocyte stimulation test
Language English
License Copyright © 2015 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c538t-190e6cf39859db54c097f35d2fe54a1ab67faa4bec1f3e33583fa65d3a8fec043
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 25863530
PQID 1680958139
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_1746881500
proquest_miscellaneous_1680958139
crossref_primary_10_1016_j_diagmicrobio_2015_03_008
pubmed_primary_25863530
elsevier_sciencedirect_doi_10_1016_j_diagmicrobio_2015_03_008
elsevier_clinicalkeyesjournals_1_s2_0_S0732889315000747
PublicationCentury 2000
PublicationDate 2015-06-01
PublicationDateYYYYMMDD 2015-06-01
PublicationDate_xml – month: 06
  year: 2015
  text: 2015-06-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Diagnostic microbiology and infectious disease
PublicationTitleAlternate Diagn Microbiol Infect Dis
PublicationYear 2015
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Takahashi, Tanaka, Tanikawa, Toyohara, Ogo, Morimoto (bb0030) 2006; 31
Nishio, Izu, Kabashima, Tokura (bb0025) 2007; 48
Chung, Hung, Yang, Su, Huang, Wei (bb0035) 2008; 14
Hanafusa, Azukizawa, Matsumura, Katayama (bb0020) 2012; 65
Yasuda, Makino, Matsuda, Kawamichi, Matsui (bb0100) 2012; 38
Miwa, Suzuki, Shirai, Ohba, Kanai, Eifuku (bb0070) 2012; 16
Nyfeler, Pichler (bb0040) 1997; 27
Blumberg, Burman, Chaisson, Daley, Etkind, Friedman (bb0075) 2003; 167
Lopez, Torres, Rodriguez-Pena, Blanca-Lopez, Fernandez, Antunez (bb0085) 2009; 160
Kawakami, Tanaka, Negoro, Morisawa, Mikami, M. (bb0060) 2007; 46
Lawn, Zumla (bb0005) 2011; 378
Aberer, Bircher, Romano, Blanca, Campi, Fernandez (bb0015) 2003; 58
Walgren, Mitchell, Thompson (bb0110) 2005; 34
Matsuno, Takenaka, Ando, Miyazaki, Kumamoto (bb0055) 2007; 3
Matsuno (bb0045) 2012; 13
Park, Kitteringham, Maggs, Pirmohamed, Williams (bb0105) 2005; 45
Ikegame, Wakamatsu, Fujita, Nakanishi, Harada, Kajiki (bb0050) 2011; 17
Martin, Wurpts, Ott, Baron, Erdmann, Merk (bb0080) 2010; 65
(bb0090) 1999; 83
Suzuki, Miwa, Shirai, Ohba, Murakami, Fujita (bb0065) 2008; 134
deShazo, Kemp (bb0095) 1997; 278
Nanashima, Mawatari, Tahara, Higuchi, Nakaura, Inamine (bb0010) 2012; 92
Blumberg (10.1016/j.diagmicrobio.2015.03.008_bb0075) 2003; 167
Hanafusa (10.1016/j.diagmicrobio.2015.03.008_bb0020) 2012; 65
Ikegame (10.1016/j.diagmicrobio.2015.03.008_bb0050) 2011; 17
Yasuda (10.1016/j.diagmicrobio.2015.03.008_bb0100) 2012; 38
Chung (10.1016/j.diagmicrobio.2015.03.008_bb0035) 2008; 14
Lopez (10.1016/j.diagmicrobio.2015.03.008_bb0085) 2009; 160
Martin (10.1016/j.diagmicrobio.2015.03.008_bb0080) 2010; 65
Lawn (10.1016/j.diagmicrobio.2015.03.008_bb0005) 2011; 378
(10.1016/j.diagmicrobio.2015.03.008_bb0090) 1999; 83
Nanashima (10.1016/j.diagmicrobio.2015.03.008_bb0010) 2012; 92
Miwa (10.1016/j.diagmicrobio.2015.03.008_bb0070) 2012; 16
Takahashi (10.1016/j.diagmicrobio.2015.03.008_bb0030) 2006; 31
Walgren (10.1016/j.diagmicrobio.2015.03.008_bb0110) 2005; 34
deShazo (10.1016/j.diagmicrobio.2015.03.008_bb0095) 1997; 278
Matsuno (10.1016/j.diagmicrobio.2015.03.008_bb0055) 2007; 3
Park (10.1016/j.diagmicrobio.2015.03.008_bb0105) 2005; 45
Nyfeler (10.1016/j.diagmicrobio.2015.03.008_bb0040) 1997; 27
Nishio (10.1016/j.diagmicrobio.2015.03.008_bb0025) 2007; 48
Suzuki (10.1016/j.diagmicrobio.2015.03.008_bb0065) 2008; 134
Aberer (10.1016/j.diagmicrobio.2015.03.008_bb0015) 2003; 58
Kawakami (10.1016/j.diagmicrobio.2015.03.008_bb0060) 2007; 46
Matsuno (10.1016/j.diagmicrobio.2015.03.008_bb0045) 2012; 13
References_xml – volume: 65
  start-page: 213
  year: 2012
  end-page: 219
  ident: bb0020
  article-title: The predominant drug-specific T-cell population may switch from cytotoxic T cells to regulatory T cells during the course of anticonvulsant-induced hypersensitivity
  publication-title: J Dermatol Sci
  contributor:
    fullname: Katayama
– volume: 34
  start-page: 325
  year: 2005
  end-page: 361
  ident: bb0110
  article-title: Role of metabolism in drug induced idiosyncratic hepatotoxicity
  publication-title: Crit Rev Toxicol
  contributor:
    fullname: Thompson
– volume: 13
  start-page: 39
  year: 2012
  ident: bb0045
  article-title: Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches
  publication-title: Respir Res
  contributor:
    fullname: Matsuno
– volume: 58
  start-page: 854
  year: 2003
  end-page: 863
  ident: bb0015
  article-title: Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations
  publication-title: Allergy
  contributor:
    fullname: Fernandez
– volume: 14
  start-page: 1343
  year: 2008
  end-page: 1350
  ident: bb0035
  article-title: Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis
  publication-title: Nat Med
  contributor:
    fullname: Wei
– volume: 16
  start-page: 1265
  year: 2012
  end-page: 1269
  ident: bb0070
  article-title: Drug lymphocyte stimulation test is not useful for side effects of anti-tuberculosis drugs despite its timing
  publication-title: Int J Tuberc Lung Dis
  contributor:
    fullname: Eifuku
– volume: 27
  start-page: 175
  year: 1997
  end-page: 181
  ident: bb0040
  article-title: The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity
  publication-title: Clin Exp Allergy
  contributor:
    fullname: Pichler
– volume: 38
  start-page: 574
  year: 2012
  end-page: 577
  ident: bb0100
  article-title: A granulocytosis associated with intravenous ritodrine hydrochloride therapy: two case reports by different mechanisms
  publication-title: J Obstet Gynaecol Res
  contributor:
    fullname: Matsui
– volume: 17
  start-page: 530
  year: 2011
  end-page: 533
  ident: bb0050
  article-title: A case of isoniazid-induced liver injury diagnosed by use of the DLST, and successful reintroduction of isoniazid for pleural tuberculosis
  publication-title: J Infect Chemother
  contributor:
    fullname: Kajiki
– volume: 92
  start-page: 253
  year: 2012
  end-page: 259
  ident: bb0010
  article-title: Genetic variants in antioxidant pathway: risk factors for hepatotoxicity in tuberculosis patients
  publication-title: Tuberculosis (Edinb)
  contributor:
    fullname: Inamine
– volume: 31
  start-page: 33
  year: 2006
  end-page: 35
  ident: bb0030
  article-title: A case of drug-induced hypersensitivity syndrome showing transient immunosuppression before viral reactivation during treatment for pemphigus foliaceus
  publication-title: Clin Exp Dermatol
  contributor:
    fullname: Morimoto
– volume: 45
  start-page: 177
  year: 2005
  end-page: 202
  ident: bb0105
  article-title: The role of metabolic activation in drug induced hepatotoxicity
  publication-title: Annu Rev Pharmacol Toxicol
  contributor:
    fullname: Williams
– volume: 160
  start-page: 259
  year: 2009
  end-page: 265
  ident: bb0085
  article-title: Lymphocyte proliferation response in patients with delayed hypersensitivity reactions to heparins
  publication-title: Br J Dermatol
  contributor:
    fullname: Antunez
– volume: 134
  start-page: 1027
  year: 2008
  end-page: 1032
  ident: bb0065
  article-title: Drug lymphocyte stimulation test in the diagnosis of adverse reactions to antituberculosis drugs
  publication-title: Chest J
  contributor:
    fullname: Fujita
– volume: 46
  start-page: 1105
  year: 2007
  end-page: 1108
  ident: bb0060
  article-title: Liver injury induced by levothyroxine in a patient with primary hypothyroidism
  publication-title: Intern Med
  contributor:
    fullname: M.
– volume: 278
  start-page: 1895
  year: 1997
  end-page: 1906
  ident: bb0095
  article-title: Allergic reactions to drugs and biologic agents
  publication-title: JAMA
  contributor:
    fullname: Kemp
– volume: 48
  start-page: 25
  year: 2007
  end-page: 33
  ident: bb0025
  article-title: T cell populations propagating in the peripheral blood of patients with drug eruptions
  publication-title: J Dermatol Sci
  contributor:
    fullname: Tokura
– volume: 3
  start-page: 70
  year: 2007
  end-page: 72
  ident: bb0055
  article-title: Amoxicillin-induced eosinophilic pneumonia with granulomatous reaction: discrepancy between drug-induced lymphocyte stimulation test findings and the provocation drug test
  publication-title: Ann Allergy Asthma Immunol
  contributor:
    fullname: Kumamoto
– volume: 65
  start-page: 32
  year: 2010
  end-page: 39
  ident: bb0080
  article-title: In vitro detection and characterization of drug hypersensitivity using flow cytometry
  publication-title: Allergy
  contributor:
    fullname: Merk
– volume: 83
  start-page: 665
  year: 1999
  end-page: 700
  ident: bb0090
  article-title: Executive summary of disease management of drug hypersensitivity: a practice parameter. Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma and Immunology, the American Academy of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology
  publication-title: Ann Allergy Asthma Immunol
– volume: 167
  start-page: 603
  year: 2003
  end-page: 662
  ident: bb0075
  article-title: American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis
  publication-title: Am J Respir Crit Care Med
  contributor:
    fullname: Friedman
– volume: 378
  start-page: 57
  year: 2011
  end-page: 72
  ident: bb0005
  article-title: Tuberculosis
  publication-title: Lancet
  contributor:
    fullname: Zumla
– volume: 83
  start-page: 665
  year: 1999
  ident: 10.1016/j.diagmicrobio.2015.03.008_bb0090
  publication-title: Ann Allergy Asthma Immunol
  doi: 10.1016/S1081-1206(10)62890-6
– volume: 46
  start-page: 1105
  year: 2007
  ident: 10.1016/j.diagmicrobio.2015.03.008_bb0060
  article-title: Liver injury induced by levothyroxine in a patient with primary hypothyroidism
  publication-title: Intern Med
  doi: 10.2169/internalmedicine.46.0086
  contributor:
    fullname: Kawakami
– volume: 27
  start-page: 175
  year: 1997
  ident: 10.1016/j.diagmicrobio.2015.03.008_bb0040
  article-title: The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity
  publication-title: Clin Exp Allergy
  doi: 10.1111/j.1365-2222.1997.tb00690.x
  contributor:
    fullname: Nyfeler
– volume: 278
  start-page: 1895
  year: 1997
  ident: 10.1016/j.diagmicrobio.2015.03.008_bb0095
  article-title: Allergic reactions to drugs and biologic agents
  publication-title: JAMA
  doi: 10.1001/jama.1997.03550220101014
  contributor:
    fullname: deShazo
– volume: 58
  start-page: 854
  year: 2003
  ident: 10.1016/j.diagmicrobio.2015.03.008_bb0015
  article-title: Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations
  publication-title: Allergy
  doi: 10.1034/j.1398-9995.2003.00279.x
  contributor:
    fullname: Aberer
– volume: 65
  start-page: 32
  year: 2010
  ident: 10.1016/j.diagmicrobio.2015.03.008_bb0080
  article-title: In vitro detection and characterization of drug hypersensitivity using flow cytometry
  publication-title: Allergy
  doi: 10.1111/j.1398-9995.2009.02143.x
  contributor:
    fullname: Martin
– volume: 378
  start-page: 57
  year: 2011
  ident: 10.1016/j.diagmicrobio.2015.03.008_bb0005
  article-title: Tuberculosis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(10)62173-3
  contributor:
    fullname: Lawn
– volume: 17
  start-page: 530
  issue: 4
  year: 2011
  ident: 10.1016/j.diagmicrobio.2015.03.008_bb0050
  article-title: A case of isoniazid-induced liver injury diagnosed by use of the DLST, and successful reintroduction of isoniazid for pleural tuberculosis
  publication-title: J Infect Chemother
  doi: 10.1007/s10156-010-0189-7
  contributor:
    fullname: Ikegame
– volume: 16
  start-page: 1265
  year: 2012
  ident: 10.1016/j.diagmicrobio.2015.03.008_bb0070
  article-title: Drug lymphocyte stimulation test is not useful for side effects of anti-tuberculosis drugs despite its timing
  publication-title: Int J Tuberc Lung Dis
  doi: 10.5588/ijtld.11.0163
  contributor:
    fullname: Miwa
– volume: 14
  start-page: 1343
  year: 2008
  ident: 10.1016/j.diagmicrobio.2015.03.008_bb0035
  article-title: Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis
  publication-title: Nat Med
  doi: 10.1038/nm.1884
  contributor:
    fullname: Chung
– volume: 65
  start-page: 213
  year: 2012
  ident: 10.1016/j.diagmicrobio.2015.03.008_bb0020
  article-title: The predominant drug-specific T-cell population may switch from cytotoxic T cells to regulatory T cells during the course of anticonvulsant-induced hypersensitivity
  publication-title: J Dermatol Sci
  doi: 10.1016/j.jdermsci.2011.12.002
  contributor:
    fullname: Hanafusa
– volume: 31
  start-page: 33
  year: 2006
  ident: 10.1016/j.diagmicrobio.2015.03.008_bb0030
  article-title: A case of drug-induced hypersensitivity syndrome showing transient immunosuppression before viral reactivation during treatment for pemphigus foliaceus
  publication-title: Clin Exp Dermatol
  doi: 10.1111/j.1365-2230.2005.01913.x
  contributor:
    fullname: Takahashi
– volume: 167
  start-page: 603
  year: 2003
  ident: 10.1016/j.diagmicrobio.2015.03.008_bb0075
  article-title: American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.167.4.603
  contributor:
    fullname: Blumberg
– volume: 3
  start-page: 70
  year: 2007
  ident: 10.1016/j.diagmicrobio.2015.03.008_bb0055
  article-title: Amoxicillin-induced eosinophilic pneumonia with granulomatous reaction: discrepancy between drug-induced lymphocyte stimulation test findings and the provocation drug test
  publication-title: Ann Allergy Asthma Immunol
  doi: 10.2310/7480.2007.00006
  contributor:
    fullname: Matsuno
– volume: 134
  start-page: 1027
  year: 2008
  ident: 10.1016/j.diagmicrobio.2015.03.008_bb0065
  article-title: Drug lymphocyte stimulation test in the diagnosis of adverse reactions to antituberculosis drugs
  publication-title: Chest J
  doi: 10.1378/chest.07-3088
  contributor:
    fullname: Suzuki
– volume: 160
  start-page: 259
  year: 2009
  ident: 10.1016/j.diagmicrobio.2015.03.008_bb0085
  article-title: Lymphocyte proliferation response in patients with delayed hypersensitivity reactions to heparins
  publication-title: Br J Dermatol
  doi: 10.1111/j.1365-2133.2008.08875.x
  contributor:
    fullname: Lopez
– volume: 13
  start-page: 39
  year: 2012
  ident: 10.1016/j.diagmicrobio.2015.03.008_bb0045
  article-title: Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches
  publication-title: Respir Res
  doi: 10.1186/1465-9921-13-39
  contributor:
    fullname: Matsuno
– volume: 92
  start-page: 253
  year: 2012
  ident: 10.1016/j.diagmicrobio.2015.03.008_bb0010
  article-title: Genetic variants in antioxidant pathway: risk factors for hepatotoxicity in tuberculosis patients
  publication-title: Tuberculosis (Edinb)
  doi: 10.1016/j.tube.2011.12.004
  contributor:
    fullname: Nanashima
– volume: 48
  start-page: 25
  year: 2007
  ident: 10.1016/j.diagmicrobio.2015.03.008_bb0025
  article-title: T cell populations propagating in the peripheral blood of patients with drug eruptions
  publication-title: J Dermatol Sci
  doi: 10.1016/j.jdermsci.2007.05.013
  contributor:
    fullname: Nishio
– volume: 38
  start-page: 574
  year: 2012
  ident: 10.1016/j.diagmicrobio.2015.03.008_bb0100
  article-title: A granulocytosis associated with intravenous ritodrine hydrochloride therapy: two case reports by different mechanisms
  publication-title: J Obstet Gynaecol Res
  doi: 10.1111/j.1447-0756.2011.01756.x
  contributor:
    fullname: Yasuda
– volume: 45
  start-page: 177
  year: 2005
  ident: 10.1016/j.diagmicrobio.2015.03.008_bb0105
  article-title: The role of metabolic activation in drug induced hepatotoxicity
  publication-title: Annu Rev Pharmacol Toxicol
  doi: 10.1146/annurev.pharmtox.45.120403.100058
  contributor:
    fullname: Park
– volume: 34
  start-page: 325
  issue: 4
  year: 2005
  ident: 10.1016/j.diagmicrobio.2015.03.008_bb0110
  article-title: Role of metabolism in drug induced idiosyncratic hepatotoxicity
  publication-title: Crit Rev Toxicol
  doi: 10.1080/10408440590935620
  contributor:
    fullname: Walgren
SSID ssj0012940
Score 2.2215803
Snippet Abstract Antituberculosis (TB) chemotherapeutic drugs may cause a variety of adverse drug reactions (ADRs). To assess the potential of drug-induced lymphocyte...
Antituberculosis (TB) chemotherapeutic drugs may cause a variety of adverse drug reactions (ADRs). To assess the potential of drug-induced lymphocyte...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 172
SubjectTerms Adolescent
Adult
Adverse drug reaction
Aged
Aged, 80 and over
Antitubercular Agents - adverse effects
Cytological Techniques - methods
Drug Hypersensitivity
Drug-induced hypersensitivity
Drug-induced lymphocyte stimulation test
Female
Humans
Infectious Disease
Internal Medicine
Lymphocyte Activation - drug effects
Male
Middle Aged
Predictive Value of Tests
Prospective Studies
Sensitivity and Specificity
Toxicology - methods
Tuberculosis
Young Adult
Title Drug-induced lymphocyte stimulation test in the prediction of drug-induced hypersensitivity to antituberculosis drugs
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0732889315000747
https://dx.doi.org/10.1016/j.diagmicrobio.2015.03.008
https://www.ncbi.nlm.nih.gov/pubmed/25863530
https://search.proquest.com/docview/1680958139
https://search.proquest.com/docview/1746881500
Volume 82
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwEB21W4G4oFKgXSiVkbiGjWM7cQ4cqkK1sGoPQEVvluM4bap2s8rHYS_8dsaJsypCRUicrFge2fGzZ57lmTHAu5Sa2FgdBVSbNED-TwOdhDwwImepZoXNjIt3PjuP5xf8y6W43IKTMRbGuVV63T_o9F5b-5qZn83Zqixn30KXZwbNLRW9IUy2YQfNEecT2Dn-vJifby4TorSPi3TtAycw5h7t3bwQhau7ckh65Dy9hM95-pCdeoiH9vbodBeeeiJJjoexPoMtu9yDR8PTkus9eHzmL82fQ_ex7q4CPHsjijm5XSN-lVm3luDuvvOvdxFknC0psby2ZFU72b66Kkh-X_oaj61145zeh1cnSFsR7SJ9u8zWprutmrLpJZoXcHH66fvJPPCvLSAuTLYBMgMbm4KlUqR5JrgJ06RgIo8KK7imOouTQmuOmNOCWcaEZIWOEVItC2tCzl7CZFkt7QEQi0rBpBQVrTU8SY1maCZpFhsqTWYTPQU2zq1aDUk11OhtdqPuI6IcIipkChGZQjLCoMawUVR0tvG7rlFUNZEK1R8rYwofNpK_LS6FduOfen47oq5w97krFb20VYc9xhI5qkQa_Zc2CY-ldGOZwv6wZDZ_HQmJjI-Fr_5zhK_hifsafNgOYdLWnX2DbKnNjmD7_U965PeEKxdffyx-AW_CGn0
link.rule.ids 315,786,790,4521,24144,27955,27956,45618,45712
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB6VraBcEBRKl6eRuEYbx3biHDhUhWpLu3uhlXqzHMdpg9rNKo_D_nvGibMqQkVInCI5HsXxZ898lucB8DmlJjZWRwHVJg2Q_9NAJyEPjMhZqllhM-PinRfLeH7Jv1-Jqx04HmNhnFul1_2DTu-1tW-Z-dmcrcty9iN0eWbQ3FLRG8LkEexykdBoArtHp2fz5fYyIUr7uEjXP3ACY-7R3s0LUbi-K4ekR87TS_icpw_ZqYd4aG-PTp7DM08kydEw1hewY1f78HgoLbnZhycLf2n-ErqvdXcd4NkbUczJ7Qbxq8ymtQR3952v3kWQcbakxOeNJevayfbNVUHy-9I3eGytG-f0PlSdIG1FtIv07TJbm-62asqml2heweXJt4vjeeCrLSAuTLYBMgMbm4KlUqR5JrgJ06RgIo8KK7imOouTQmuOmNOCWcaEZIWOEVItC2tCzg5gsqpW9hCIRaVgUoqK1hqepEYzNJM0iw2VJrOJngIb51ath6QaavQ2-6nuI6IcIipkChGZQjLCoMawUVR0tvG7rlFUNZEK1R8rYwpftpK_LS6FduOfvvxpRF3h7nNXKnplqw6_GEvkqBJp9F_6JDyW0o1lCq-HJbP960hIZHwsfPOfI_wIe_OLxbk6P12evYWn7s3gz_YOJm3d2ffInNrsg98ZvwBeHxrK
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Drug-induced+lymphocyte+stimulation+test+in+the+prediction+of+drug-induced+hypersensitivity+to+antituberculosis+drugs&rft.jtitle=Diagnostic+microbiology+and+infectious+disease&rft.au=Sun%2C+Qin&rft.au=Sha%2C+Wei&rft.au=Gui%2C+Xu-Wei&rft.au=Xiao%2C+Yang-Jiong&rft.date=2015-06-01&rft.pub=Elsevier+Inc&rft.issn=0732-8893&rft.eissn=1879-0070&rft.volume=82&rft.issue=2&rft.spage=172&rft.epage=176&rft_id=info:doi/10.1016%2Fj.diagmicrobio.2015.03.008&rft.externalDocID=S0732889315000747
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F07328893%2FS0732889315X00058%2Fcov150h.gif